|
Breast (TNBC)
|
miR-199a
| |
Proliferation and apoptosis
|
28961506
|
|
Cervical cancer
|
miR-186
| |
Cancer development
|
28550682
|
|
Oral cancer
|
miR-125a
| |
Cell proliferation, migration, and invasion
|
29635126
|
|
Hepatocellular carcinoma
|
miR-122-5p
| |
Cell proliferation, invasion, and metastasis
|
29127494
|
|
miR-153-5p
|
ARHGAP18
|
Metastasis
|
30510148
|
|
miR-384
|
STAT3
| |
31679275
|
|
miR-191
|
NF-κB and Wnt/β-catenin
|
Apoptosis, proliferation, metastasis, and invasion
|
30249208
|
|
let-7c-5p
|
NAP1L1
| |
30165194
|
|
miR-122-5p
| |
Cell proliferation, metastasis, and invasion
|
29127494
|
|
Gastric cancer
|
miR-99a
|
BMI1, Bcl-2
|
Cancer development
|
30156609
|
|
Colorectal
|
let-7a
|
ATP-binding cassette subfamily C member 1
| |
30279206
|
|
Prostate cancer
|
let-7a
|
TGF-β1/Smad
|
Proliferation and migration
|
29278879
|
|
Glioma
|
miR-34a
|
Sirt1, PI3K/AKT, and mTOR
|
Cell proliferation, migration, and invasion
|
29057547
|
|
Retinoblastoma
|
miR-99a
|
c-MYC
|
Apoptosis, proliferation, metastasis and invasion
|
31184221
|
|
miR-24
|
c-MYC, MEK/ERK, and Wnt/β-catenin
|
Viability, migration, and invasion
|
30703428
|
|
Osteosarcoma
|
miR-125a-5p
|
STAT3
|
Cisplatin chemoresistance
|
30777616
|
|
Nasopharyngeal carcinoma
|
miR-125a
| | |
28402230
|
|
let-7a
| |
Cisplatin chemoresistance
|
28117929
|
|
Medulloblastoma
|
miR-323
|
BRI3 and CDK6, p38 MAPK, ERK, and AKT, Wnt signaling
|
Cell proliferation and migration through miR-323-mediated regulation of BRI3
|
28513871
|
